NCT03854721View on ClinicalTrials.gov

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Urothelial Carcinoma of the Urinary Bladder
Interventions
DRUG

VAX014

Solution for intravesical infusion, 3.33x10\^10 rBMCs per vial

Trial Locations (5)

29572

Carolina Urologic Research Center, Myrtle Beach

52242

University of Iowa Hospital and Clinics, Iowa City

77030

Baylor College of Medicine, Houston

80211

The Urology Center of Colorado, Denver

08837

New Jersey Urology, LLC., Edison

Sponsors
All Listed Sponsors
lead

Vaxiion Therapeutics

INDUSTRY